Caladrius Biosciences, Inc. (CLBS)

Oncology Corporate Profile

Stock Performance

4.8700
-0.2900

HQ Location

420 Lexington Avenue, Suite 350
New York, NY 10170

Company Description

Caladrius Biosciences, Inc. (Caladrius, formerly NeoStem) is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, and manufacturing. Caladrius is a cell therapy leader with late-stage clinical programs based on a proprietary platform technology for immuno-oncology, as well as additional platform technologies for ischemic repair and immunomodulation, and capabilities that support other cell therapy developers. This integrated approach supports the industry in bringing significant life-improving medical treatments to market.

Website: http://www.caladrius.com/

This company does not have any commercial products

This company does not have any pipeline products

Pipeline image

Source


http://www.caladrius.com/

Recent News Headlines

Caladrius Biosciences Announces 2016 Fourth Quarter and Full Year Financial Results

3/17/2017 11:00 am

[GlobeNewswire] - Annual revenue growth of 57% exceeds 2016 financial guidance. Conference call begins today at 8:30 am Eastern time. BASKING RIDGE, N.J., March 17, 2017-- Caladrius Biosciences, Inc., a cell therapy company ...

Hitachi Chemical Signs Agreement to Purchase from Caladrius Biosciences the Remaining 80.1% Interest in PCT for $75 Million

3/16/2017 11:03 pm

[GlobeNewswire] - Caladrius expected to emerge as a well-capitalized cell therapeutics-only development company with multiple proprietary technology platforms. Conference call begins tomorrow, March 17, 2017 at 8:30 am ...

Caladrius Biosciences to Host 2016 Fourth Quarter and Full Year Financial Results Conference Call on March 17, 2017 at 8:30 am Eastern Time

3/13/2017 11:03 am

[GlobeNewswire] - BASKING RIDGE, N.J., March 13, 2017-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...

Caladrius Biosciences to Present at Upcoming March Conferences

3/2/2017 12:03 pm

[GlobeNewswire] - BASKING RIDGE, N.J., March 02, 2017-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...

Caladrius Biosciences Awarded $12.2 Million Grant from CIRM in Support of Phase 2 Clinical Trial of CLBS03 to Treat Type 1 Diabetes

2/23/2017 06:04 pm

[GlobeNewswire] - BASKING RIDGE, N.J., Feb. 23, 2017-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...

Caladrius Biosciences to Present at Upcoming February Conferences

2/1/2017 12:03 pm

[GlobeNewswire] - BASKING RIDGE, N.J., Feb. 01, 2017-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...

Caladrius Biosciences Announces Addition of Three Clinical Sites, Including University of California, San Francisco, for the Ongoing Phase 2 Study of CLBS03 in T1D

1/25/2017 12:03 pm

[GlobeNewswire] - BASKING RIDGE, N.J., Jan. 25, 2017-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...

Caladrius Biosciences Updates Status of Receipt of Funds for a Portion of Previously Announced Private Placement

1/6/2017 09:01 pm

[at noodls] - BASKING RIDGE, N.J., Jan. 6, 2017 - Caladrius Biosciences, Inc. (NASDAQ:CLBS) ('Caladrius' or the 'Company'), a cell therapy company combining a select therapeutic development pipeline with an industry-leading ...

Caladrius Biosciences Updates Status of Receipt of Funds for a Portion of Previously Announced Private Placement

1/6/2017 09:00 pm

[GlobeNewswire] - BASKING RIDGE, N.J., Jan. 06, 2017-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...

Caladrius Biosciences to Present at Upcoming January Conferences

1/3/2017 12:03 pm

[GlobeNewswire] - BASKING RIDGE, N.J., Jan. 03, 2017-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...

Caladrius Biosciences to Present at Upcoming December Conferences

12/5/2016 12:03 pm

[GlobeNewswire] - BASKING RIDGE, N.J., Dec. 05, 2016-- Caladrius Biosciences, Inc., a cell therapy company combining a select therapeutic development pipeline with an industry-leading development and manufacturing services ...